Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

25.59
-0.1132-0.44%
Post-market: 25.590.00000.00%16:10 EDT
Volume:1K
Turnover:29.50K
Market Cap:5.12M
PE:- -
High:25.59
Open:25.51
Low:25.51
Close:25.70
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:1.52
T/O Rate:0.58%
Dividend:0.41
Dividend Rate:1.62%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Scholar Rock announces FDA approval of isembyld

TIPRANKS
·
14 hours ago

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy Patients Aged 2 and Older on SMN2 Therapy

Reuters
·
14 hours ago

Scholar Rock Holding Corporation - Isembyld U.S. Commercial Launch Underway; Product Available to Ship in Coming Days

THOMSON REUTERS
·
14 hours ago

Scholar Rock Announces FDA Approval of Isembyld™ (Apitegromab-Mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (Sma)

THOMSON REUTERS
·
14 hours ago

US FDA Approves Scholar Rock's Muscle Weakness Drug

Reuters
·
15 hours ago

US FDA - Approves Isembyld for Spinal Muscular Atrophy in Patients Aged 2 Years and Older

THOMSON REUTERS
·
15 hours ago

Scholar Rock Holdings trading halted, news pending

TIPRANKS
·
16 hours ago

NASDAQ Trade Halt Halt News Pending at 05:07 Pm

Reuters
·
16 hours ago

Sector Update: Healthcare

MT Newswires Live
·
17 hours ago

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
17 hours ago

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
19 hours ago

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
21 hours ago

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Yesterday

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Yesterday

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Yesterday

Hims & Hers Health Price Target Announced at $32.00/Share by JP Morgan

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-Novo Nordisk, Oracle, Adobe

Reuters
·
Yesterday

Novo Nordisk Stock (NVO) Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

TIPRANKS
·
Yesterday

Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Yesterday

Morgan Stanley downgrades Novo Nordisk (0QIU) to a Sell

TIPRANKS
·
Yesterday